The Brain Barriers Research Center is a distinctive research group involving many disciplines at the University of Minnesota, including the College of Pharmacy and the School of Medicine, dedicated to using cutting edge technologies in the treatment of brain disorders.
The Center for Clinical and Cognitive Neuropharmacology promotes interdisciplinary research investigating the interaction between individual patient characteristics and the effect of drugs on cognition.
The Center for Drug Design (CDD) was created to combine research and scholarship leading to the development of novel drugs for therapeutic applications, such as HIV, cancer, neurological diseases, dermatological agents, infectious diseases, novel processes, and medical devices.
The Center for Forecasting Drug Response is as a resource to researchers in the Department of Experimental and Clinical Pharmacology, the College of Pharmacy, the University of Minnesota and the community. There are three constituent divisions of the CFDR: Analytics, Pharmacometrics and Pharmacogenomics, each facilitated by an associated service.
The Center for Orphan Drug Research researches new drug therapies, educates health professionals and health profession students, and contributes to the discussion and formulation of public policy relating to rare diseases and orphan drugs to improve the care of individuals suffering from rare diseases.
The Epilepsy Research and Education Program research focuses on antiepileptic drug clinical pharmacology, epidemiology and economics, practice models and outcomes including epilepsy surgery.
The Institute for Therapeutics Discovery and Development conducts research and educates in the area of drug discovery and development and offers scientific services to research and business communities in the area of drug discovery and development.
The Minnesota Pharmacy Practice Based Research Network collects information using a network of pharmacies to help address societal and community questions related to the medication use process.
IPM is a distinctive research group of investigators from various disciplines dedicated to advancing the field of pharmacogenomics to help prescribe the right medicine at the right dose and thus improve the safety and efficacy of currently prescribed medications.
The PRIME Institute is an independent and global research, education and consulting organization whose mission is the study of the economic and policy issues to help improve popular access to pharmaceuticals and pharmaceutical services.
The Wulling Center for Innovation & Scholarship in Pharmacy Education (W-CISPE) advances pharmacy education by supporting our member faculty and fostering collaborative relationships. We are dedicated to focused and deliberate educational innovations and rigorous educational scholarship.